BlackRock’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Sell |
369,048
-2,808,855
| -88% | -$1.03M | ﹤0.01% | 4694 |
|
|
2025
Q1 | $823K | Buy |
3,177,903
+14,723
| +0.5% | +$3.82K | ﹤0.01% | 4202 |
|
|
2024
Q4 | $1.78M | Buy |
3,163,180
+258,009
| +9% | +$145K | ﹤0.01% | 4013 |
|
|
2024
Q3 | $1.74M | Buy |
2,905,171
+414,922
| +17% | +$249K | ﹤0.01% | 3987 |
|
|
2024
Q2 | $6.72M | Buy |
2,490,249
+2,318,348
| +1,349% | +$6.26M | ﹤0.01% | 3526 |
|
|
2024
Q1 | $882K | Buy |
171,901
+91,225
| +113% | +$468K | ﹤0.01% | 4170 |
|
|
2023
Q4 | $43.3K | Buy |
80,676
+43,249
| +116% | +$23.2K | ﹤0.01% | 4911 |
|
|
2023
Q3 | $24.8K | Sell |
37,427
-3,978
| -10% | -$2.64K | ﹤0.01% | 5047 |
|
|
2023
Q2 | $62.9K | Buy |
41,405
+8,654
| +26% | +$13.2K | ﹤0.01% | 4936 |
|
|
2023
Q1 | $62.2K | Sell |
32,751
-4,791
| -13% | -$9.1K | ﹤0.01% | 4992 |
|
|
2022
Q4 | $35.7K | Buy |
37,542
+676
| +2% | +$642 | ﹤0.01% | 5204 |
|
|
2022
Q3 | $42K | Sell |
36,866
-845
| -2% | -$963 | ﹤0.01% | 5304 |
|
|
2022
Q2 | $52K | Sell |
37,711
-507
| -1% | -$699 | ﹤0.01% | 5307 |
|
|
2022
Q1 | $96K | Buy |
38,218
+13,936
| +57% | +$35K | ﹤0.01% | 5207 |
|
|
2021
Q4 | $146K | Buy |
24,282
+445
| +2% | +$2.68K | ﹤0.01% | 5102 |
|
|
2021
Q3 | $186K | Buy |
+23,837
| New | +$186K | ﹤0.01% | 4935 |
|